Subrat Khanal

Dr. Subrat Khanal

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2018 in Biomedicines
Verified
Journal Article
Open access
PDF file
SKSubrat Khanal
Subrat Khanal
PGPranita Ghimire
Pranita Ghimire
ADAmit Dhamoon
Amit Dhamoon
Adenoviridae is a family of double-stranded DNA viruses that are a significant cause of upper respiratory tract infections in children and adults. Less commonly, the adenovirus family can cause a variety of gastrointestinal, ophthalmologic, genitourinary, and neurologic diseases. Most adenovirus infections are self-limited in the immunocompetent host and are treated with supportive measures. Fatal infections can occur in immunocompromised patients and less frequently in the healthy. Adenoviral vectors are being studied for novel biomedical applications including gene therapy and immunization. In this review we will focus on the spectrum of adenoviral infections in humans.

29 January 2018 in Preprints.org
Verified
Preprint
Open access
SKSubrat Khanal
Subrat Khanal
PGPranita Ghimire
Pranita Ghimire
ADAmit S. Dhamoon
Amit S. Dhamoon
Adenovirus is a family of double stranded DNA viruses that are a significant cause of upper respiratory tract infections in children and adults. Less commonly, the adenovirus family can cause a variety of gastrointestinal, ophthalmologic, genitourinary, and neurologic diseases. Most adenovirus infections are self-limited in the immunocompetent host and are treated with supportive measures. Fatal infections can occur in immunocompromised patients and less frequently in the healthy. Adenoviral vectors are being studied for novel biomedical applications including gene therapy and immunization. In this review we will focus on the spectrum of adenoviral infections in humans.


31 May 2022 in Cureus
Verified
Journal Article
Open access
SMSindhubarathi Murali
Sindhubarathi Murali
SKSubrat Khanal
Subrat Khanal
SBSanchari Banerjee
Sanchari Banerjee
OCOmari Christie
Omari Christie
KRKartik Ramakrishna
Kartik Ramakrishna
Severe pulmonary arterial hypertension (PAH) is associated with high morbidity and mortality. Therapeutic approaches for intermediate- and high-risk pulmonary arterial hypertension have now shifted toward initial combination management, often including parenteral epoprostenol and iloprost and early assessment for a lung transplant. After the initiation of therapy, usually various combinations of different classes of medication, it is important to consider the potential interruption in therapy causing rebound PAH. We present two patients recently admitted to our hospital with rebound symptoms after interruption of their pulmonary vasodilator therapy.

24 January 2022 in Cureus
Verified
Journal Article
Open access
SKSubrat Khanal
Subrat Khanal
SMSindhubarathi Murali
Sindhubarathi Murali
PGPranita Ghimire
Pranita Ghimire
ACAndrew Chu
Andrew Chu
We present a 26-year-old African-American gentleman with no significant past medical history who presented with a three-day history of dry cough. Computerized tomography of the chest showed scattered infiltrates consistent with a pseudo-miliary pattern. A transbronchial biopsy showed non-caseating granulomas confirming our suspicion for pulmonary sarcoidosis. Miliary sarcoidosis is rare; therefore, health care providers should consider other diagnoses such as tuberculosis, malignancy, and pneumoconiosis.